Annexin Pharmaceuticals AB (publ) (STO:ANNX)

STO:ANNX Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.4	16.34	21.42	31.11	49.48
Cash & Short-Term Investments	27.4	16.34	21.42	31.11	49.48
Cash Growth	67.69%	-23.71%	-31.17%	-37.12%	172.88%
Other Receivables	0.38	0.42	2.63	1.86	1.02
Receivables	0.38	0.42	2.63	1.86	1.02
Prepaid Expenses	0.79	0.63	0.87	0.67	0.22
Total Current Assets	28.57	17.38	24.92	33.65	50.72
Property, Plant & Equipment	1.12	1.08	1.17	1.26	1.35
Long-Term Investments	0.31	0.31	0.31	0.41	0.15
Other Intangible Assets	0.16	0.27	0.37	0.47	0.58
Other Long-Term Assets	-	-	-	0.89	-
Total Assets	30.16	19.04	26.76	36.68	52.79
Accounts Payable	2.97	2.96	4.33	3.33	3.51
Accrued Expenses	1.93	1.98	3.3	2.43	1.7
Other Current Liabilities	0.33	0.39	0.32	0.77	0.84
Total Current Liabilities	5.22	5.32	7.95	6.53	6.06
Total Liabilities	5.22	5.32	7.95	6.53	6.06
Common Stock	11.68	8.82	5.74	2.56	27.45
Additional Paid-In Capital	386.61	341.36	299.29	269.63	220.91
Retained Earnings	-373.36	-336.46	-286.21	-242.16	-201.63
Comprehensive Income & Other	-	-	-	0.12	-
Shareholders' Equity	24.93	13.71	18.81	30.15	46.73
Total Liabilities & Equity	30.16	19.04	26.76	36.68	52.79
Net Cash (Debt)	27.4	16.34	21.42	31.11	49.48
Net Cash Growth	67.69%	-23.71%	-31.17%	-37.12%	172.88%
Net Cash Per Share	4.14	3.61	12.82	21.27	60.31
Filing Date Shares Outstanding	7.06	5.33	3.47	1.54	1.37
Total Common Shares Outstanding	7.06	5.33	3.47	1.54	1.37
Working Capital	23.34	12.06	16.97	27.12	44.66
Book Value Per Share	3.53	2.57	5.43	19.52	34.05
Tangible Book Value	24.77	13.45	18.44	29.68	46.15
Tangible Book Value Per Share	3.51	2.52	5.32	19.21	33.63

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.